Matrix-M1 Uses, Dosage, Side Effects and more
Matrix-M1 is a saponin-based adjuvant made of nanometer particles, cholesterol, and phospholipid that is developed by Novavax. This compound is administered alongside vaccines to enhance biological functions: creating robust and long-lasting immune responses that may allow for dose-sparing of vaccines.
| Trade Name | Matrix-M1 |
| Generic | Matrix-M |
| Matrix-M Other Names | Matrix-M1, Matrix-M1 Adjuvant |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
How Matrix-M1 works
Matrix-M1 can enhance activated T-cell, B-cell, and antigen-presenting cell populations by inducing the influx of antigen-presenting cells. It can also enhance both B-cell immunity and T-cell immunity.
